GENEURO SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.43 EUR | 0.00% |
|
0.00% | +31.19% |
| Mar. 20 | Geneuro SA Announces Appointments of Board of Directors | CI |
| Feb. 02 | GeNeuro: share price falls after private placement | CF |
Chart calendar GeNeuro SA
c57b77a59d3d1f3ee191858f0998.G30qatRYgbUs9BW8nF65d7xJ61-Ot2D1Oj-9iIboH7k.VBpmC5Zp0NB8kFHt9wboT_A9iAv9-jWGfFjzwLSYW-pPMAcZixztxEuiZg~6f2e3ae7cc85dbbf0fa2e9df326b662e
Upcoming events on GeNeuro SA
Past events on GeNeuro SA
| 2024-04-03 | Investor Access Event |
| 2024-04-01 | Q4 2023 Earnings Release (Projected) |
| 2024-03-27 | Smallcap Event |
| 2024-03-17 | Extraordinary Shareholders Meeting |
| 2023-10-08 | Investor Access Event |
| 2023-10-03 | Bio Future Conference |
| 2023-10-02 01:30 am | Q2 2023 Earnings Release |
| 2023-06-14 09:00 am | Annual General Meeting |
| 2023-06-04 | BIO International Convention |
| 2023-05-24 | Gilbert Dupont Midcaps Forum |
| 2023-05-02 | LSX World Congress |
| 2023-04-05 01:30 am | Q4 2022 Earnings Release |
| 2022-10-10 | International Society of Neuro Virology Symposium |
| 2022-10-05 | Investor Meeting |
| 2022-09-29 12:30 pm | Interim 2022 Earnings Release |
| 2022-09-27 | Lyon Pole Bourse Conference |
| 2022-09-20 | Sachs Associates Biotech in Europe Forum |
| 2022-06-27 | Gilbert Dupont Midcaps Forum |
| 2022-06-12 | BIO International Convention |
| 2022-05-30 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 7,46 24,0 -68.9% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million EUR | Released Forecast Spread | -8,02 -0,60 -1236.65% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -11,3 |
|
EBIT Million EUR | Released Forecast Spread | -8,09 -0,60 -1248.1% | -8,99 -24,4 63.14% | -7,46 -11,0 32.24% | -6,37 -14,1 54.69% | -11,2 -7,15 -57% | -11,3 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -8,33 -0,60 -1287.97% | -9,46 -14,1 32.9% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Net income Million EUR | Released Forecast Spread | -8,33 -0,60 -1287.97% | -9,46 -24,5 61.46% | -8,96 -11,3 20.45% | -6,82 -14,4 52.56% | -12,2 -7,28 -67.67% | -11,3 |
|
EPS EUR | Released Forecast Spread | -0,57 -0,04 -1325% | -0,65 -0,96 32.39% | -0,45 -0,62 27.8% | -0,32 -0,28 -12.58% | -0,51 -0,29 -75.22% | -0,43 |
| Announcement Date | 01/04/19 | 07/04/20 | 06/04/21 | 04/04/22 | 05/04/23 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 |
|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 |
|
Net income Million EUR | Released Forecast Spread | -3,40 |
|
EPS EUR | Released Forecast Spread | -0,17 |
| Announcement Date | 29/09/21 |
More events
Past sector events for GeNeuro SA
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GNRO Stock
- Calendar GeNeuro SA
